TABLE 2.
Positivity of HIV-1 Western blot and Geenius assays at 12 and 24 weeks after initiation of ART at FI, FII, or FIII/IVa
Result | % of samples with the indicated result |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Wk 12 |
Wk 24 |
|||||||||||
FI |
FII |
FIII/IV |
FI |
FII |
FIII/IV |
|||||||
WB | GN | WB | GN | WB | GN | WB | GN | WB | GN | WB | GN | |
POS | 25.0 | 25.0 | 65.8 | 44.7 | 72.7 | 59.1 | 30.4 | 26.1 | 73.7 | 50.0 | 59.1 | 45.5 |
IND | 37.5 | 20.8 | 31.6 | 52.6 | 27.3 | 40.9 | 21.7 | 21.7 | 21.1 | 44.7 | 36.4 | 45.5 |
NEG | 37.5 | 54.2 | 2.6 | 2.6 | 0.0 | 0.0 | 47.8 | 52.2 | 5.3 | 5.3 | 4.5 | 9.1 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
A high percentage of samples tested at 12 and 24 weeks of ART remained negative or indeterminate when therapy was initiated early. WB, Western blot assay; GN, Geenius assay. POS, positive; IND, indeterminate; NEG, negative.